(287 days)
The Hydrocolloid Dressing is intended for the management of lightly to moderately exudating wounds by absorbing exudate and by maintaining a moist wound environment. The moist wound environment supports autolytic debridement. The dressing backing allows for gas exchange. The dressing is indicated for use in the following types of wounds: venous stasis ulcers, pressure ulcers, surgical incision sites, and minor burns.
Not Found
I'm sorry, but this document does not contain information about acceptance criteria or a study proving device performance. This is a 510(k) clearance letter from the FDA for a wound dressing, indicating that the device is substantially equivalent to a predicate device and can be marketed. It outlines the indications for use and certain labeling restrictions.
Therefore, I cannot provide the requested table or answer the specific questions about a study and its details as they are not present in the provided text.
N/A